1. Kranick SM, Nath A. Neurologic Complications of HIV-1 Infection and Its Treatment in the Era of Antiretroviral Therapy. Cont Lifelong Learn Neurol 2012;18(6):1319-37 [
DOI:10.1212/01.CON.0000423849.24900.ec] [
PMID] [
PMCID]
2. Lindo JF, Dubon JM, Ager AL, De Gourville EM, Solo-Gabriele H, Klaskala WI, Baum MK, Palmer CJ. Intestinal parasitic infections in human immunodeficiency virus (HIV)-positive and HIV-negative individuals in San Pedro Sula, Honduras. Am J Trop Med Hygiene 1998;58(4):431-5. [
DOI:10.4269/ajtmh.1998.58.431] [
PMID]
3. Schulz TF, Boshoff CH, Weiss RA. HIV infection and neoplasia. Lancet 1996; 587-91. [
DOI:10.1016/S0140-6736(95)11033-X] [
PMID]
4. UNAIDS. 2017. Fact sheet July 2017. UNAIDS, Geneva, Switzerland. www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Accessed 11 November 2017 [
URL]
5. UNAIDS. 2015. Treatment 2015. UNAIDS, Geneva, Switzerland. www.unaids.org/sites/default/files/media_asset/JC2484_treatment-2015_en _1.pdf. Accessed 7 March 2018. [
URL]
6. UNAIDS. 2017. Fact sheet-World AIDS Day 2017. UNAIDS, Geneva, Switzerland. www.unaids.org/sites/default/files/media_asset/UNAIDS _FactSheet_en.pdf. Accessed 2 April 2018. [
URL]
7. Parekh BS, Ou CY, Fonjungo PN. Kalou MB, Rottinghaus E, Puren A, et al. Diagnosis of Human Immunodeficiency Virus Infection. Clin Micro Rev 2019;32(1):1-55 [
DOI:10.1128/CMR.00064-18] [
PMID] [
PMCID]
8. Gontran M, Jerome LT, Yvonne AM, Mavoungou-Poaty V, Elie M, Brice O, et al. Effects of IM28 on HIV-1 and Metabolic Disorders-induced Highly Active Antiretroviral Therapy in Gabonese Patients. J Antivir Antiretrovir 2009; 1:76-81. [
Google Scholar]
9. Montessori V, Press N, Harris M, Adverse effects of antiretroviral therapy for HIV infection. Can Med Assoc J 2004;170(2):229-38. [
Google Scholar]
10. Subbaraman R, Chaguturu KS, Mayer KH. Adverse Effects of Highly Active Antiretroviral Therapy in Developing Countries. Clin Infec Dis 2007;45(8):1093-101. [
DOI:10.1086/521150] [
PMID]
11. Victoria NU, Sunday NO. Assessment of highly active antiretroviral therapy (HAART) adherence among HIV patients in a tertiary health institution in Nigeria. Afri J Pharm and Pharm 2014;8(47):1192-9. [
Google Scholar]
12. Patel AK, Patel KK. Future implications: Compliance and failure with Future implications: Compliance and failure with antiretroviral treatment antiretroviral treatment antiretroviral treatment. J Postgrad Med 2006;52(3):197-200. [
Google Scholar]
13. Uakarn C, Chaokromthong K, Sintao N. Sample Size Estimation using Yamane and Cochran and Krejcie and Morgan and Green Formulas and Cohen Statistical Power Analysis by G*Power and Comparisons. Apheit Intern J 2021;10(2):76-88. [
Google Scholar]
14. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2010 revision. World Health Organization; 2010. [
URL]
15. Lartey M, Quashie AA, Essel A, Kenu E, Ganu V, Neequaye A, et al. Adverse drug reactions to antiretroviral therapy during the early art period at a tertiary hopital in Ghana. Pan Afr Med J 2014; 18:25. [
DOI:10.11604/pamj.2014.18.25.3886] [
PMID] [
PMCID]
16. Sadiq S, Gupta S, Khajuria V, Tandon VR, Mahajan A, Gupta M. et al. Adverse drug events due to Antiretroviral Therapy in a Northern Indian Tertiary Care Institution. Natl J Physiol Pharm Pharm 2016; 6:205-8 [
DOI:10.5455/njppp.2016.6.31012016114]
17. Abdela J, Assefa A, Shamele S. Prevalence of Adverse Drug Reactions among Pediatric Patients on Antiretroviral Therapy in Selected Hospitals in Eastern Ethiopia: 8-Year Retrospective Cross-Sectional Study. J Int Ass Provider AIDS Care 2019; 18:1-7. [
DOI:10.1177/2325958218823208] [
PMID] [
PMCID]
18. Eluwa GI, Badru T, Akpoigbe KJ. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clin Pharm 2012; 12:7.
https://doi.org/10.1186/1472-6904-12-14 [
DOI:10.1186/1472-6904-12-7] [
PMCID]
19. Sharma A, Vora R, Modi M. Adverse effects of antiretroviral treatment. Indian J Dermatol Venereol Leprol 2008;74(3):234-7. [
DOI:10.4103/0378-6323.41368] [
PMID]
20. Menezez de Pádua CA, César CC, Bonolo PF. High incidence of adverse reactions to intial antiretroviral therapy in Brazil. Braz J Med Biol Res 2006; 39:495-505. [
DOI:10.1590/S0100-879X2006000400010] [
PMID]
21. Keiser O, Fellay J, Opravil M, Hirsch HH, Hirschel B, Bernasconi E et al. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification. Antivir Ther 2007; 12:1157-64. [
DOI:10.1177/135965350701200808] [
PMID]
22. Oshikoya KA, Lawal S, Oreagba IA. Adverse Events in HIV-infected Children on Antiretroviral Therapy at a Teaching Hospital in Lagos, Nigeria: A Retrospective Study. Adv Pharmacoepidem Drug Saf 2012; 1:117. [
Google Scholar]
23. Obiako OR, Haruna MM, Sani GB, Eric T, Adebola OT, Mathew I et al. Adverse reactions associated with antiretroviral regimens in adult patients of a university teaching hospital HIV program in Zaria, Northern Nigeria: an observational cohort study. J Antivir Antiretrovir 2012; 4:6-13. [
Google Scholar]
24. Verweel G, Sharland M, Lyall H, Novelli V, Gibb DM, Dumont G, et al. Nevirapine use in HIV-1- infected children. AIDS 2003; 17:1639-47. [
DOI:10.1097/00002030-200307250-00008] [
PMID]
25. Arisudhana GB, Sofro MU, Sujianto U. Antiretroviral Side Effects on Adherence in People Living with HIV/AIDS. Nurse Media J Nurs 2018;8(2):79-85 [
DOI:10.14710/nmjn.v8i2.20742]
26. Ezhilarasan D, Srilekha M, Raghu R. HAART and Hepatotoxicity. J App Pharm Sci 2017;7(04):220-6. [
Google Scholar]
27. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD Hepatotoxicity Associated With Nevirapine or Efavirenz-Containing Antiretroviral Therapy: Role of Hepatitis C and B Infections. Hep 2002; 35:182-9 [
DOI:10.1053/jhep.2002.30319] [
PMID]
28. Pryce C, Pierre RB, Steel-Duncan J, Evans-Gilbert T, Palmer P, et al. Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS. West Indian Med J 2008; 57:238-45. [
Google Scholar]
29. Shah I. Adverse effects of antiretroviral therapy in HIV-1- infected children. J Trop Ped 2006; 52:244-8. [
DOI:10.1093/tropej/fmi086] [
PMID]